GlobalData Epidemiologist Report: Global Covid infections pass 67.7 million – vaccinations begin in UK
8 December Globally, the total confirmed cases of Covid-19 have reached over 67,719,000, with more than 1,547,000 deaths and 43,639,000…
8 December Globally, the total confirmed cases of Covid-19 have reached over 67,719,000, with more than 1,547,000 deaths and 43,639,000…
11 June The Covid-19 pandemic has led to widespread unemployment and potential bankruptcies of businesses and companies across the world.…
Vir Biotechnology and GlaxoSmithKline (GSK) have reported that an independent Data and Safety Monitoring Board (DSMB) has recommended halting enrolment in the VIR-7831 (GSK4182136) arm…
Amgen has reported positive data from the Phase III study of BLINCYTO (blinatumomab) in paediatric patients with high-risk first-relapse B-cell precursor acute lymphoblastic leukaemia (B-ALL).…
On 1 March, Merck announced the voluntary withdrawal of its Keytruda (pembrolizumab) immunotherapy for the treatment of patients with metastatic…
Science 37 has collaborated with digital health and telemedicine company Medgate to further globalise decentralised clinical trials. With presence in…
ObvioHealth is set to initiate a Phase II/III study of RedHill Biopharma’s RHB-107 (upamostat) in the US for Covid-19 treatment.…
The US National Institutes of Health (NIH) has put on hold a trial of convalescent blood plasma in treating patients…
COSELA™ (trilaciclib) is the first approved myeloprotection therapy indicated to reduce the occurrence of chemotherapy-induced bone marrow suppression in adult…
UKONIQ™ (umbralisib) is the first and only oral, dual inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
In the past few months, two new warehouses were erected and put into operation on the IKA premises. IKA continues…